Drugs / Trimethoprim/polymyxin B
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03920007 Background | Sep 2019 → May 2023 overdue | Leber congenital amaurosis 1 | Atsena Therapeutics Inc. | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trimethoprim/polymyxin B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03920007 ↗ |
| Route | Topical | “Route of administration: Topical” NCT03920007 ↗ |